Back to mobile site

Oramed Pharma (ORMP) Announces $20M Buy-Back of its Common Stock

June 26, 2024 9:02 AM EDT Send to a Friend
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (the "Company") (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login